Advertisement
Screener

Collegium Pharmaceutical, Inc. (COLL) Proceeds from Stock Options Exercised

2.8 / 5 stars · 68/120 Roast Me

Collegium Pharmaceutical, Inc. Proceeds from Stock Options Exercised

Collegium Pharmaceutical, Inc. (COLL) reported Proceeds from Stock Options Exercised of $875.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Financing Activities

us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-08-06

  • Collegium Pharmaceutical, Inc. proceeds from stock options exercised for the quarter ending 2026-06-30 was $481.00K, a 56.17% increase year-over-year.
  • Collegium Pharmaceutical, Inc. proceeds from stock options exercised for the quarter ending 2026-03-31 was $394.00K, a 74.61% decline year-over-year.
  • Collegium Pharmaceutical, Inc. proceeds from stock options exercised for the quarter ending 2025-12-31 was $985.00K, a 469.36% increase year-over-year.
  • Collegium Pharmaceutical, Inc. proceeds from stock options exercised for the quarter ending 2025-09-30 was $1.44M, a 863.09% increase year-over-year.
  • Collegium Pharmaceutical, Inc. proceeds from stock options exercised for fiscal 2025 was $4.28M, a 58.23% decline from fiscal 2024.
  • Collegium Pharmaceutical, Inc. proceeds from stock options exercised for fiscal 2024 was $10.25M, a 18.57% increase from fiscal 2023.
  • Collegium Pharmaceutical, Inc. proceeds from stock options exercised for fiscal 2023 was $8.64M, a 26.84% decline from fiscal 2022.
  • Collegium Pharmaceutical, Inc. proceeds from stock options exercised for fiscal 2022 was $11.81M, a 1.18% decline from fiscal 2021.
Period endProceeds from Stock Options Exercised 3 monthProceeds from Stock Options Exercised 6 monthProceeds from Stock Options Exercised 9 monthProceeds from Stock Options Exercised 12 month
2026-06-30$481.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$875.00K
10-Q · filed 2026-08-06
$1.86M
derived: sum of 3 quarters · filed 2026-08-06
$3.29M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$394.00K
10-Q · filed 2026-05-07
$1.38M
derived: sum of 2 quarters · filed 2026-05-07
$2.81M
derived: sum of 3 quarters · filed 2026-05-07
$3.12M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$985.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$2.42M
derived: sum of 2 quarters · filed 2026-02-26
$2.73M
derived: sum of 3 quarters · filed 2026-08-06
$4.28M
10-K · filed 2026-02-26
2025-09-30$1.44M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$1.74M
derived: sum of 2 quarters · filed 2026-08-06
$3.29M
10-Q · filed 2025-11-06
$3.47M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$308.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$1.86M
10-Q · filed 2026-08-06
$2.03M
derived: sum of 3 quarters · filed 2026-08-06
$2.18M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$1.55M
10-Q · filed 2026-05-07
$1.73M
derived: sum of 2 quarters · filed 2026-05-07
$1.87M
derived: sum of 3 quarters · filed 2026-05-07
$7.59M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$173.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$322.00K
derived: sum of 2 quarters · filed 2026-02-26
$6.04M
derived: sum of 3 quarters · filed 2026-02-26
$10.25M
10-K · filed 2026-02-26
2024-09-30$149.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$5.87M
derived: sum of 2 quarters · filed 2025-11-06
$10.07M
10-Q · filed 2025-11-06
$13.31M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$5.72M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$9.92M
10-Q · filed 2025-08-07
$13.16M
derived: sum of 3 quarters · filed 2026-02-26
$13.47M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$4.21M
10-Q · filed 2025-05-08
$7.45M
derived: sum of 2 quarters · filed 2026-02-26
$7.75M
derived: sum of 3 quarters · filed 2026-02-26
$9.00M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$3.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$3.54M
derived: sum of 2 quarters · filed 2026-02-26
$4.79M
derived: sum of 3 quarters · filed 2026-02-26
$8.64M
10-K · filed 2026-02-26
2023-09-30$302.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$1.55M
derived: sum of 2 quarters · filed 2024-11-07
$5.40M
10-Q · filed 2024-11-07
$12.26M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30$1.25M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$5.10M
10-Q · filed 2024-08-08
$11.96M
derived: sum of 3 quarters · filed 2025-02-27
$12.10M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31$3.85M
10-Q · filed 2024-05-09
$10.71M
derived: sum of 2 quarters · filed 2025-02-27
$10.85M
derived: sum of 3 quarters · filed 2025-02-27
$12.40M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$6.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$7.00M
derived: sum of 2 quarters · filed 2025-02-27
$8.55M
derived: sum of 3 quarters · filed 2025-02-27
$11.81M
10-K · filed 2025-02-27
2022-09-30$142.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$1.69M
derived: sum of 2 quarters · filed 2023-11-07
$4.95M
10-Q · filed 2023-11-07
$7.29M
derived: sum of 4 quarters · filed 2024-02-22
2022-06-30$1.54M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
$4.81M
10-Q · filed 2023-08-03
$7.14M
derived: sum of 3 quarters · filed 2024-02-22
$8.48M
derived: sum of 4 quarters · filed 2024-02-22
2022-03-31$3.26M
10-Q · filed 2023-05-04
$5.60M
derived: sum of 2 quarters · filed 2024-02-22
$6.94M
derived: sum of 3 quarters · filed 2024-02-22
$11.03M
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31$2.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$3.68M
derived: sum of 2 quarters · filed 2024-02-22
$7.77M
derived: sum of 3 quarters · filed 2024-02-22
$11.95M
10-K · filed 2024-02-22
2021-09-30$1.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$5.43M
derived: sum of 2 quarters · filed 2022-11-03
$9.61M
10-Q · filed 2022-11-03
$9.80M
derived: sum of 4 quarters · filed 2023-02-23
2021-06-30$4.09M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$8.27M
10-Q · filed 2022-08-04
$8.46M
derived: sum of 3 quarters · filed 2023-02-23
$8.77M
derived: sum of 4 quarters · filed 2023-02-23
2021-03-31$4.18M
10-Q · filed 2022-05-10
$4.37M
derived: sum of 2 quarters · filed 2023-02-23
$4.68M
derived: sum of 3 quarters · filed 2023-02-23
$6.30M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31$183.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$497.00K
derived: sum of 2 quarters · filed 2023-02-23
$2.12M
derived: sum of 3 quarters · filed 2023-02-23
$6.58M
10-K · filed 2023-02-23
2020-09-30$314.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$1.94M
derived: sum of 2 quarters · filed 2021-11-04
$6.39M
10-Q · filed 2021-11-04
$7.91M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$1.63M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$6.08M
10-Q · filed 2021-08-05
$7.59M
derived: sum of 3 quarters · filed 2022-02-24
$7.83M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31$4.45M
10-Q · filed 2021-05-06
$5.97M
derived: sum of 2 quarters · filed 2022-02-24
$6.20M
derived: sum of 3 quarters · filed 2022-02-24
$6.29M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$1.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$1.75M
derived: sum of 2 quarters · filed 2022-02-24
$1.83M
derived: sum of 3 quarters · filed 2022-02-24
$2.05M
10-K · filed 2022-02-24
2019-09-30$232.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$318.00K
derived: sum of 2 quarters · filed 2020-11-05
$531.00K
10-Q · filed 2020-11-05
$699.00K
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$86.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$299.00K
10-Q · filed 2020-08-05
$467.00K
derived: sum of 3 quarters · filed 2021-02-25
$649.00K
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$213.00K
10-Q · filed 2020-05-07
$381.00K
derived: sum of 2 quarters · filed 2021-02-25
$563.00K
derived: sum of 3 quarters · filed 2021-02-25
$2.10M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$168.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$350.00K
derived: sum of 2 quarters · filed 2021-02-25
$1.88M
derived: sum of 3 quarters · filed 2021-02-25
$4.25M
10-K · filed 2021-02-25
2018-09-30$182.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
$1.71M
derived: sum of 2 quarters · filed 2019-11-06
$4.09M
10-Q · filed 2019-11-06
$4.39M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30$1.53M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$3.90M
10-Q · filed 2019-08-07
$4.21M
derived: sum of 3 quarters · filed 2020-02-27
$4.23M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31$2.37M
10-Q · filed 2019-05-08
$2.68M
derived: sum of 2 quarters · filed 2020-02-27
$2.69M
derived: sum of 3 quarters · filed 2020-02-27
$3.02M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$308.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$321.00K
derived: sum of 2 quarters · filed 2020-02-27
$642.00K
derived: sum of 3 quarters · filed 2020-02-27
$736.00K
10-K · filed 2020-02-27
2017-09-30$13.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$334.00K
derived: sum of 2 quarters · filed 2018-11-08
$428.00K
10-Q · filed 2018-11-08
$757.00K
derived: sum of 4 quarters · filed 2019-02-27
2017-06-30$321.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08
$415.00K
10-Q · filed 2018-08-08
$744.00K
derived: sum of 3 quarters · filed 2019-02-27
$772.00K
derived: sum of 4 quarters · filed 2019-02-27
2017-03-31$94.00K
10-Q · filed 2018-05-09
$423.00K
derived: sum of 2 quarters · filed 2019-02-27
$451.00K
derived: sum of 3 quarters · filed 2019-02-27
$495.00K
derived: sum of 4 quarters · filed 2019-02-27
2016-12-31$329.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
$357.00K
derived: sum of 2 quarters · filed 2019-02-27
$401.00K
derived: sum of 3 quarters · filed 2019-02-27
$443.00K
10-K · filed 2019-02-27
2016-09-30$28.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
$72.00K
derived: sum of 2 quarters · filed 2017-11-08
$114.00K
10-Q · filed 2017-11-08
$159.00K
derived: sum of 4 quarters · filed 2018-03-07
2016-06-30$44.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$86.00K
10-Q · filed 2017-08-09
$131.00K
derived: sum of 3 quarters · filed 2018-03-07
$132.00K
derived: sum of 4 quarters · filed 2018-03-07
2016-03-31$42.00K
10-Q · filed 2017-05-10
$87.00K
derived: sum of 2 quarters · filed 2018-03-07
$88.00K
derived: sum of 3 quarters · filed 2018-03-07
$99.00K
derived: sum of 4 quarters · filed 2018-03-07
2015-12-31$45.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07
$46.00K
derived: sum of 2 quarters · filed 2018-03-07
$57.00K
derived: sum of 3 quarters · filed 2018-03-07
$517.00K
10-K · filed 2018-03-07
2015-09-30$1.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
$12.00K
derived: sum of 2 quarters · filed 2016-11-10
$472.00K
10-Q · filed 2016-11-10
$535.00K
derived: sum of 4 quarters · filed 2017-03-10
2015-06-30$11.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11
$471.00K
10-Q · filed 2016-08-11
$534.00K
derived: sum of 3 quarters · filed 2017-03-10
$542.00K
derived: sum of 4 quarters · filed 2017-03-10
2015-03-31$460.00K
10-Q · filed 2016-05-11
$523.00K
derived: sum of 2 quarters · filed 2017-03-10
$531.00K
derived: sum of 3 quarters · filed 2017-03-10
$531.00K
derived: sum of 4 quarters · filed 2017-03-10
2014-12-31$63.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10
$71.00K
derived: sum of 2 quarters · filed 2017-03-10
$71.00K
derived: sum of 3 quarters · filed 2017-03-10
$72.00K
10-K · filed 2017-03-10
2014-09-30$8.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
$8.00K
derived: sum of 2 quarters · filed 2015-11-12
$9.00K
10-Q · filed 2015-11-12
2014-06-30$0.00
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-08-12
$1.00K
10-Q · filed 2015-08-12
2014-03-31$1.00K
10-Q/A · filed 2015-07-17
2013-12-31$1.00K
10-K · filed 2016-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Faeth Therapeutics, Inc. (FTH)United States$0.750B
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78
Verastem, Inc. (VSTM)United States$0.706B-1.71
Nuvectis Pharma, Inc. (NVCT)United States$0.705B-17.53
IRONWOOD PHARMACEUTICALS INC (IRWD)United States$0.694B5.37
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
Climb Bio, Inc. (CLYM)United States$0.683B-13.03
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
GERON CORP (GERN)United States$0.803B-12.14